Aczone (Dapsone Gel 5%)
Aczone is topical Dapsone Gel 5% and was originally created as an acne treatment. Recent efforts by the owners of Aczone, Allergan, have attempted to position Aczone as a rosacea treatment.
Recent Rosacea Blog Posts
We don’t often get to see the actual results from clinical trials. Companies are happy to receive publicity for their research and development programs, especially if a new product looks promising. If things don’t go we during clinical trials, though, it seems that we just never hear about that product again. Allergan, the makes of […]
News today that Allergan are buying the privately held pharmaceutical company Vicept Therapuetics. The aim of many small startup companies is to be acquired by a larger company, Vicept telling us that “We believe Allergan is the best company to complete the development and make the therapy available to the clinical community and their patients, […]
Trolling patent applications is pretty turgid work. Mostly patents seem to be intellectuals marking out their claims in the hope that future products might result from their discoveries. This patent application starts badly with firstly spelling Rosacea incorrectly as Rosascea. Pretty embarrassing Allergan ! To save you from seeing this misspelling again I’ll spell it […]
The FDA has issued a warning letter to Allergan, the makers of Aczone for overstating the efficacy of Aczone and also for understating the possible side effects. In a sign that the FDA is watching carefully the claims that vendors use when advertising their products, the warning letter calls out a journal advertisement for Aczone […]
OK this story is getting so much coverage in the online press that I thought I should cover it here too. Allergan is buying the topical dapsone product called Aczone for $150m. From: Allergan Announces Agreement to Acquire Aczone(R) Gel 5% “Aczone(R) Gel 5% is the first new chemical entity approved by the FDA for […]
